Geode Capital Management, LLC Annovis Bio, Inc. Transaction History
Geode Capital Management, LLC
- $1.12 Trillion
- Q2 2024
A detailed history of Geode Capital Management, LLC transactions in Annovis Bio, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 76,233 shares of ANVS stock, worth $665,514. This represents 0.0% of its overall portfolio holdings.
Number of Shares
76,233
Previous 70,791
7.69%
Holding current value
$665,514
Previous $842,000
47.86%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ANVS
# of Institutions
47Shares Held
946KCall Options Held
642KPut Options Held
1.57M-
Vanguard Group Inc Valley Forge, PA361KShares$3.15 Million0.0% of portfolio
-
Black Rock Inc. New York, NY101KShares$879,1890.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA100KShares$873,0000.0% of portfolio
-
Wescott Financial Advisory Group, LLC41.6KShares$363,2290.03% of portfolio
-
Sterling Investment Advisors, Ltd.34.5KShares$300,9580.07% of portfolio
About Annovis Bio, Inc.
- Ticker ANVS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,163,920
- Market Cap $71.3M
- Description
- Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...